3649 results for «480»
3649 results
PCI for complex bifurcation disease - LIVE Case
23 May 2025 – From EuroPCR 2025
A 60-year-old male patient presented with an inferior STEMI one month ago, which was treated with RCA and LCx PCI. He was referred for LAD/diagonal PCI. The LV function was reduced (EF 45 %). The team performed a DK crush PCI, guided by IVUS.
LIVE Educational Case...
When strange things happen, CTO and complications
23 May 2025 – From EuroPCR 2025
This session addresses complications and unexpected challenges encountered in chronic total occlusion (CTO) interventions. Learn from cases involving retrieval of stuck wires, coronary perforations, and strategies to manage complex and unusual procedural difficulties.
Through decisions in complex left main PCI - Left main restenosis
23 May 2025 – From EuroPCR 2025
Gain comprehensive understanding of left main restenosis mechanisms, diagnostic evaluation, and treatment options. This session includes case presentations with angiographic and intracoronary imaging assessments, explores the role of imaging in management decisions, and reviews therapeutic strategies including repeat stenting, drug-eluting balloons, and coronary artery bypass grafting.
Challenges and complications in coronary interventions
23 May 2025 – From EuroPCR 2025
Discuss real-world challenges and complications in coronary interventions including heavily calcified LAD PCI, cardiac crisis management, and rare intramural hematoma cases. The session emphasizes the importance of IVUS guidance and operator expertise in complex scenarios.
Three-year results of HOST-POLYTECH-ACS RCT comparing durable- vs. degradable-polymer DES
30 Aug 2023
Alex Sticchi provides his take on the 3-year results of HOST-POLYTECH-ACS RCT which were presented by Hyo-Soo Kim during the ESC 2023 congress in Amsterdam.
Author
Management of mitral regurgitation patients undergoing TMVI screening
13 Jan 2022
This study's results emphasise the strengths and limitations of transcatheter mitral valve implantation (TMVI) as a novel and promising therapy providing predictable elimination of MR in most patients, by S. Ludwig et al.
Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Ballon with Conventional Ballon Angioplasty for In-Stent Restenosis (AGENT IDE)
27 Oct 2023
Mirvat Alasnag provides her take on the AGENT IDE trial which was presented by Robert W. Yeh at TCT Congress 2023. This pivotal randomized trial compares the safety and efficacy of the AGENT DCB to conventional balloon angioplasty in patients with ISR. It is the first...
Author
SIRONA completes enrollment! A leap in the DCB treatment of femoropopliteal arterial disease
02 Nov 2022
When transfemoral TAVI is not an option: rethinking alternative access strategies
18 Jun 2026
In this article, Ulrich Schäfer explores the evolving landscape of access strategies in transcatheter aortic valve implantation (TAVI). While the transfemoral approach remains the gold standard, a significant proportion of patients are not suitable due to peripheral vascular disease or anatomical constraints.
Drawing on clinical evidence and...
Author
